A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. Researchers have discovered that an experimental compound called K884 can boost the natural repair abilities of muscle stem cells. Current treatments can slow muscle damage, but don’t address the root problem.
Categories
Recent Posts
- MD trial update: 5 OPMD patients safely treated with gene therapy
- Solid Biosciences Shares Initial Data from INSPIRE DUCHENNE Study of Gene Therapy Candidate SGT-003
- A week in the life of an overwhelmed caregiver
- Phase 1 trial of SAT-3247 finishes enrolling healthy volunteers
- It started with shoes, but now everything is too heavy